NCT01843829 - A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2016

Conditions

Oesophageal Cancer

Interventions

DRUG

Oxaliplatin

DRUG

Capecitabine

DRUG

Carboplatin

DRUG

Paclitaxel

RADIATION

Radiotherapy

PROCEDURE

Surgery

Patients will have their tumour surgically removed by two-phase oesophagectomy and two-field lymphadenectomy.

Trial Locations (12)

Unknown

RECRUITING

Bristol Oncology and Haematology Centre, Bristol

RECRUITING

Valindre NHS, Cardiff

RECRUITING

University Hospitals Coventry and Warwickshire, Coventry

NOT_YET_RECRUITING

Royal Derby Hospital, Derby

RECRUITING

St James's Hospital, Leeds

RECRUITING

Leicester Royal Infirmary, Leicester

RECRUITING

St Mary's Hopsital, London

RECRUITING

The Christie, Manchester

RECRUITING

Churchill Hospital, Oxford

RECRUITING

Weston Park Hospital, Sheffield

RECRUITING

Southampton General Hospital, Southampton

RECRUITING

The Great Western Hospital, Swindon